327 related articles for article (PubMed ID: 30847930)
1. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
[TBL] [Abstract][Full Text] [Related]
2. Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.
Wenner MM; Taylor HS; Stachenfeld NS
J Physiol; 2011 Oct; 589(Pt 19):4671-9. PubMed ID: 21825025
[TBL] [Abstract][Full Text] [Related]
3. Androgens influence microvascular dilation in PCOS through ET-A and ET-B receptors.
Wenner MM; Taylor HS; Stachenfeld NS
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E818-25. PubMed ID: 23921139
[TBL] [Abstract][Full Text] [Related]
4. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome.
Berbrier DE; Leone CA; Adler TE; Bender JR; Taylor HS; Stachenfeld NS; Usselman CW
J Appl Physiol (1985); 2023 Apr; 134(4):868-878. PubMed ID: 36861670
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.
Sprung VS; Cuthbertson DJ; Pugh CJ; Daousi C; Atkinson G; Aziz NF; Kemp GJ; Green DJ; Cable NT; Jones H
J Physiol; 2013 Mar; 591(6):1475-87. PubMed ID: 23318877
[TBL] [Abstract][Full Text] [Related]
6. ET
Shoemaker LN; Haigh KM; Kuczmarski AV; McGinty SJ; Welti LM; Hobson JC; Edwards DG; Feinberg RF; Wenner MM
Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H592-H598. PubMed ID: 34415188
[TBL] [Abstract][Full Text] [Related]
7. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
[TBL] [Abstract][Full Text] [Related]
8. Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.
Stanhewicz AE; Jandu S; Santhanam L; Alexander LM
Clin Sci (Lond); 2017 Dec; 131(23):2777-2789. PubMed ID: 29042489
[TBL] [Abstract][Full Text] [Related]
9. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome is associated with endothelial dysfunction.
Paradisi G; Steinberg HO; Hempfling A; Cronin J; Hook G; Shepard MK; Baron AD
Circulation; 2001 Mar; 103(10):1410-5. PubMed ID: 11245645
[TBL] [Abstract][Full Text] [Related]
11. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
12. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Rajendran S; Willoughby SR; Chan WP; Liberts EA; Heresztyn T; Saha M; Marber MS; Norman RJ; Horowitz JD
Atherosclerosis; 2009 Jun; 204(2):509-14. PubMed ID: 19027116
[TBL] [Abstract][Full Text] [Related]
14. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors.
Sánchez A; Martínez P; Muñoz M; Benedito S; García-Sacristán A; Hernández M; Prieto D
Br J Pharmacol; 2014 Dec; 171(24):5682-95. PubMed ID: 25091502
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
Mancini F; Cianciosi A; Reggiani GM; Facchinetti F; Battaglia C; de Aloysio D
Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
18. ET
Wenner MM; Sebzda KN; Kuczmarski AV; Pohlig RT; Edwards DG
Am J Physiol Regul Integr Comp Physiol; 2017 Jul; 313(1):R51-R57. PubMed ID: 28438762
[TBL] [Abstract][Full Text] [Related]
19. Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
Naka KK; Kalantaridou SN; Bechlioulis A; Kravariti M; Kazakos N; Katsouras CS; Tsatsoulis A; Michalis LK
Gynecol Endocrinol; 2011 Sep; 27(9):615-21. PubMed ID: 21329419
[TBL] [Abstract][Full Text] [Related]
20. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
